Cocrystal Pharma, Inc. - Product Pipeline Review - 2016

  • ID: 3802750
  • Company Profile
  • 44 pages
  • Global Markets Direct
1 of 3
Cocrystal Pharma, Inc. - Product Pipeline Review - 2016

Summary

‘Cocrystal Pharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Cocrystal Pharma, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Cocrystal Pharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The author's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from their proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Cocrystal Pharma, Inc.
- The report provides overview of Cocrystal Pharma, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Cocrystal Pharma, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Cocrystal Pharma, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Cocrystal Pharma, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Cocrystal Pharma, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cocrystal Pharma, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 3
List of Tables

List of Figures

Cocrystal Pharma, Inc. Snapshot

Cocrystal Pharma, Inc. Overview

Key Information

Key Facts

Cocrystal Pharma, Inc. - Research and Development Overview

Key Therapeutic Areas

Cocrystal Pharma, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Cocrystal Pharma, Inc. - Pipeline Products Glance

Cocrystal Pharma, Inc. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Cocrystal Pharma, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Cocrystal Pharma, Inc. - Drug Profiles

CC-31244

Product Description

Mechanism of Action

R&D Progress

CC-1845

Product Description

Mechanism of Action

R&D Progress

CC-2068

Product Description

Mechanism of Action

R&D Progress

CC-2069

Product Description

Mechanism of Action

R&D Progress

CDI-244

Product Description

Mechanism of Action

R&D Progress

Gene Therapy for Hepatitis B and Human Papilloma Virus Infections

Product Description

Mechanism of Action

R&D Progress

CC-31326

Product Description

Mechanism of Action

R&D Progress

RS-1137

Product Description

Mechanism of Action

R&D Progress

RS-1142

Product Description

Mechanism of Action

R&D Progress

RS-1145

Product Description

Mechanism of Action

R&D Progress

RS-930

Product Description

Mechanism of Action

R&D Progress

RS-961

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Hepatitis C

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit PB2 for Influenza

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit RNA Dependent RNA Polymerase for Norovirus Infections

Product Description

Mechanism of Action

R&D Progress

Cocrystal Pharma, Inc. - Pipeline Analysis

Cocrystal Pharma, Inc. - Pipeline Products by Target

Cocrystal Pharma, Inc. - Pipeline Products by Route of Administration

Cocrystal Pharma, Inc. - Pipeline Products by Molecule Type

Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action

Cocrystal Pharma, Inc. - Recent Pipeline Updates

Cocrystal Pharma, Inc. - Dormant Projects

Cocrystal Pharma, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer 44List of Tables

Cocrystal Pharma, Inc., Key Information

Cocrystal Pharma, Inc., Key Facts

Cocrystal Pharma, Inc. - Pipeline by Indication, 2016

Cocrystal Pharma, Inc. - Pipeline by Stage of Development, 2016

Cocrystal Pharma, Inc. - Monotherapy Products in Pipeline, 2016

Cocrystal Pharma, Inc. - Out-Licensed Products in Pipeline, 2016

Cocrystal Pharma, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Cocrystal Pharma, Inc. - Phase I, 2016

Cocrystal Pharma, Inc. - Preclinical, 2016

Cocrystal Pharma, Inc. - Discovery, 2016

Cocrystal Pharma, Inc. - Pipeline by Target, 2016

Cocrystal Pharma, Inc. - Pipeline by Route of Administration, 2016

Cocrystal Pharma, Inc. - Pipeline by Molecule Type, 2016

Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action, 2016

Cocrystal Pharma, Inc. - Recent Pipeline Updates, 2016

Cocrystal Pharma, Inc. - Dormant Developmental Projects,2016

Cocrystal Pharma, Inc., Other Locations 42List of Figures

Cocrystal Pharma, Inc. - Pipeline by Indication, 2016

Cocrystal Pharma, Inc. - Pipeline by Stage of Development, 2016

Cocrystal Pharma, Inc. - Monotherapy Products in Pipeline, 2016

Cocrystal Pharma, Inc. - Pipeline by Target, 2016

Cocrystal Pharma, Inc. - Pipeline by Route of Administration, 2016

Cocrystal Pharma, Inc. - Pipeline by Molecule Type, 2016

Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll